-
-
-
-
-
-
-
Quanterix Releases Financial Results for the Third Quarter of 2025
-
-
-
-
-
-
-
Quanterix Completes Acquisition of Akoya Biosciences, Creating the First Integrated Platform Capable of Measuring Biomarkers Across the Blood and Tissue Continuum
-
-
-
-
-
-
-
Quanterix Releases Financial Results for the First Quarter of 2025
-
-
-
-
-
-
-
Quanterix Corp. (QTRX) PT Lowered to $18 at Scotiabank
-
-
-
-
-
-
-
Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results
-
-
-
-
-
-
-
Canaccord Genuity Reiterates Buy Rating on Quanterix Corp. (QTRX)
-
-
-
-
-
-
-
INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Qaunterix Corporation (NASDAQ: QTRX) Investors with losses to Contact the FirmĀ
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

